Global Proglumide Market Size By Type of Formulation (Oral Tablets, Injectable Formulations), By Indication (Gastrointestinal Disorders, Off-label Uses), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies), By Geographic Scope And Forecast
Report ID: 360441|No. of Pages: 202
Global Proglumide Market Size By Type of Formulation (Oral Tablets, Injectable Formulations), By Indication (Gastrointestinal Disorders, Off-label Uses), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies), By Geographic Scope And Forecast
Proglumide Market Size And Forecast
Proglumide Market size was valued at USD 8.33 Million in 2023 and is projected to reach USD 12.81 Million by 2031, growing at a CAGR of 5.53% from 2024 to 2031.
Global Proglumide Market Drivers
The market drivers for the Proglumide Market can be influenced by various factors. These may include:
- Clinical Research and Development: The market may expand as a result of ongoing clinical trials and investigations into Proglumide’s potential as a treatment for ailments like obesity, addiction, and gastrointestinal issues. Positive results from these investigations could lead to a rise in Proglumide demand.
- Increased Prevalence of Gastrointestinal diseases: With the prevalence of gastrointestinal diseases, including functional dyspepsia and irritable bowel syndrome (IBS), continuing to rise in the population, there is an increasing demand for efficient therapies. Proglumide’s market expansion may be fueled by its potential as a treatment option for various ailments.
- Growing Obesity Rates: Finding safe and practical ways to manage weight is a continuous endeavor, as obesity is a global health concern. Proglumide may be attractive in this market area due to its potential to lower food consumption and aid in weight loss.
- Growing Knowledge and Acceptance of Functional Foods and Supplements: As people become more conscious of the value of wellness and nutrition, there is a growing market for functional foods and supplements that provide health advantages over and beyond that of standard diet. Proglumide, a useful chemical with certain health benefits, may find a niche in this industry.
- Possibility for New Therapeutic Applications: In addition to its customary uses, Proglumide may have additional therapeutic uses that are discovered via continued study, which would increase its market potential. This might cover things like treatment for substance misuse, mood problems, and pain management.
- Regulatory Approvals and Market Expansion: By making Proglumide more accessible to patients and healthcare professionals, regulatory approvals for the drug in a number of jurisdictions might greatly accelerate its market expansion.
- Partnerships and Collaborations: Partnerships among academic institutions, pharmaceutical companies, and research facilities may hasten the development and launch of proglumide-based treatments, hence propelling the market’s expansion.
Global Proglumide Market Restraints
Several factors can act as restraints or challenges for the Proglumide Market. These may include:
- Limited Clinical Evidence: Although early research has shown promise, there may yet be insufficient clinical evidence to support Proglumide’s safety and efficacy across a range of therapeutic applications. Patients’ and healthcare professionals’ widespread adoption may be hampered by the lack of solid clinical data.
- Regulatory Obstacles: The regulatory clearance procedures pertaining to drugs may be protracted and demanding. Proglumide’s commercialization and market expansion may be hampered by delays or challenges in getting regulatory clearances in certain areas.
- Safety Concerns: Proglumide, like all medications, may have safety risks or adverse effects, especially when used long-term or in certain patient populations. Any safety concerns found during post-marketing surveillance or clinical trials may result in market withdrawal or regulatory delays.
- Competition from Developed Therapies: Proglumide is being studied in therapeutic areas where there may already be formulated medications with safety and efficacy characteristics that have been demonstrated. It may be difficult to persuade patients and healthcare professionals to move from these well-established medicines to Proglumide.
- Patent Expiration and Generic Competition: Generic competition may arise if Proglumide or its formulations are not sufficiently protected by patents, which could result in price erosion and decreased profitability for producers.
- Segmentation of the Market and Variable Therapeutic Targets: Proglumide has the potential to treat a wide range of illnesses, including obesity, addiction, and gastrointestinal issues. It may be difficult to successfully satisfy the unique demands and preferences of each market segment due to the diversity of possible target markets.
- Limited Market Knowledge and Education: Patients’ and healthcare professionals’ knowledge of Proglumide’s possible therapeutic advantages may be restricted. To improve knowledge and comprehension of Proglumide’s advantages, potential indications, and modes of action, effective marketing and educational campaigns may be required.
Global Proglumide Market Segmentation Analysis
The Global Proglumide Market is Segmented on the basis of Type of Formulation, Indication, Distribution Channel, and Geography.
Type of Formulation:
- Oral Tablets: Proglumide is often available in oral tablet form, which is convenient for daily administration.
- Injectable Formulations: Some formulations of proglumide may be available for injection, typically used in hospital settings or for patients unable to take oral medication.
Indication:
- Gastrointestinal Disorders: Proglumide is primarily indicated for gastrointestinal conditions such as dyspepsia, gastroesophageal reflux disease (GERD), and functional dyspepsia.
- Off-label Uses: Proglumide may also be used off-label for conditions such as opioid-induced constipation and bile reflux.
Distribution Channel:
- Retail Pharmacies: Proglumide may be available through traditional retail pharmacies for over-the-counter or prescription purchases.
- Hospital Pharmacies: Some formulations may be distributed through hospital pharmacies for inpatient use or administration by healthcare professionals.
- Online Pharmacies: Increasingly, proglumide may be available for purchase through online platforms and specialty pharmacies.
Geography:
- North America: Market conditions and demand in the United States, Canada, and Mexico.
- Europe: Analysis of the Proglumide Market in European countries.
- Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.
- Middle East and Africa: Examining market dynamics in the Middle East and African regions.
- Latin America: Covering market trends and developments in countries across Latin America.
Key Players
- Tianyuan Pharma Chemical Institute
- Santa Cruz Biotechnology Inc.
- AK Scientific
- Toronto Research Chemicals
- Regis Technologies
- Bio-Techne Corporation
- MedChem Express
- ChemScence
- Nanjing Pharmaceutical Factory Co.Ltd.
- AdvaCare Pharma
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| STUDY PERIOD | 2019-2031 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2031 |
| HISTORICAL PERIOD | 2020-2022 |
| UNIT | Value (USD Million) |
| KEY COMPANIES PROFILED | Tianyuan Pharma Chemical Institute, Santa Cruz Biotechnology, Inc., AK Scientific, Toronto Research Chemicals, Regis Technologies, Bio-Techne Corporation, MedChem Express, ChemScence, & Others |
| SEGMENTS COVERED | By Type of Formulation, By Indication, By Distribution Channel, and By Geography. |
| CUSTOMIZATION SCOPE | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly Get in touch with our sales team.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
TABLE OF CONTENTS
1 INTRODUCTION
1.1 MARKET DEFINITION
1.2 MARKET SEGMENTATION
1.3 RESEARCH TIMELINES
1.4 ASSUMPTIONS
1.5 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 DATA MINING
2.2 SECONDARY RESEARCH
2.3 PRIMARY RESEARCH
2.4 SUBJECT MATTER EXPERT ADVICE
2.5 QUALITY CHECK
2.6 FINAL REVIEW
2.7 DATA TRIANGULATION
2.8 BOTTOM-UP APPROACH
2.9 TOP-DOWN APPROACH
2.10 RESEARCH FLOW
3 EXECUTIVE SUMMARY
3.1 GLOBAL PROGLUMIDE MARKET OVERVIEW
3.2 GLOBAL PROGLUMIDE MARKET ESTIMATES AND FORECAST (USD MILLION), 2021-2030
3.3 GLOBAL PROGLUMIDE MARKET VALUE (USD MILLION) AND FORECAST, 2021-2030
3.4 GLOBAL PROGLUMIDE MARKET ECOLOGY MAPPING (% SHARE IN 2022)
3.5 COMPETITIVE ANALYSIS: FUNNEL DIAGRAM
3.6 GLOBAL PROGLUMIDE MARKET ABSOLUTE MARKET OPPORTUNITY
3.7 GLOBAL PROGLUMIDE MARKET ATTRACTIVENESS ANALYSIS, BY REGION
3.8 GLOBAL PROGLUMIDE MARKET ATTRACTIVENESS ANALYSIS, BY TYPE
3.9 GLOBAL PROGLUMIDE MARKET ATTRACTIVENESS ANALYSIS, BY APPLICATION
3.10 GLOBAL PROGLUMIDE MARKET ATTRACTIVENESS ANALYSIS, BY END-USER
3.11 GLOBAL PROGLUMIDE MARKET ATTRACTIVENESS ANALYSIS, BY DISTRIBUTION CHANNEL
3.12 GLOBAL PROGLUMIDE MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
3.13 GLOBAL PROGLUMIDE MARKET, BY TYPE (USD MILLION)
3.14 GLOBAL PROGLUMIDE MARKET, BY APPLICATION (USD MILLION)
3.15 GLOBAL PROGLUMIDE MARKET, BY END-USER (USD MILLION)
3.16 GLOBAL PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL (USD MILLION)
3.17 FUTURE MARKET OPPORTUNITIES
4 MARKET OUTLOOK
4.1 GLOBAL PROGLUMIDE MARKET EVOLUTION
4.2 GLOBAL PROGLUMIDE MARKET OUTLOOK
4.3 MARKET DRIVERS
4.3.1 GROWING PREVALENCE OF GASTROINTESTINAL DISEASE
4.3.2 GROWING GERIATRIC POPULATION
4.4 MARKET RESTRAINTS
4.4.1 AVAILABILITY OF ALTERNATIVE DRUGS
4.4.2 SURGE IN THE USE OF NATURAL HOME REMEDIES AND AYURVEDIC TREATMENTS FOR STOMACH ULCER
4.5 MARKET TRENDS
4.5.1 DIGITAL HEALTH AND TELEMEDICINE
4.6 MARKET OPPORTUNITY
4.6.1 USE OF PROGLUMIDE IN PAIN MANAGEMENT
4.7 PORTER’S FIVE FORCES ANALYSIS
4.7.1 THREAT OF NEW ENTRANTS
4.7.2 THREAT OF SUBSTITUTES
4.7.3 BARGAINING POWER OF SUPPLIERS
4.7.4 BARGAINING POWER OF BUYERS
4.7.5 INTENSITY OF COMPETITIVE RIVALRY
4.8 MACROECONOMIC ANALYSIS
4.9 REGULATIONS
4.9.1 GOOD MANUFACTURING PRACTICES:
4.9.2 REGISTRATION AND LICENSING:
4.9.3 QUALITY CONTROL:
4.9.4 DOCUMENTATIONS:
4.9.5 PATENT PROTECTION:
4.9.6 IMPORT AND EXPORT REGULATIONS:
4.9.7 PRESCRIPTION AND DISPENSING:
4.9.8 PRICE CONTROLS AND REIMBURSEMENT:
4.10 VALUE CHAIN ANALYSIS
4.11 PRICING ANALYSIS
4.12 PRODUCT LIFELINE
5 MARKET, BY TYPE OF FORMULATION
5.1 OVERVIEW
5.2 ORAL TABLETS
5.3 INJECTABLE FORMULATIONS
6 MARKET, BY INDICATION
6.1 OVERVIEW
6.2 GASTROINTESTINAL DISORDERS
6.3 OFF-LABEL USES
7 MARKET, BY DISTRIBUTION CHANNEL
7.1 OVERVIEW
7.2 RETAIL PHARMACIES
7.3 HOSPITAL PHARMACIES
7.4 ONLINE PHARMACIES
9 MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA MARKET SNAPSHOT
9.2.2 U.S.
9.2.3 CANADA
9.2.4 MEXICO
9.3 EUROPE
9.3.1 EUROPE MARKET SNAPSHOT
9.3.2 GERMANY
9.3.3 U.K.
9.3.4 FRANCE
9.3.5 ITALY
9.3.6 SPAIN
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC MARKET SNAPSHOT
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 INDIA
9.4.5 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 LATIN AMERICA MARKET SNAPSHOT
9.5.2 BRAZIL
9.5.3 ARGENTINA
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST AND AFRICA
9.6.1 MIDDLE EAST AND AFRICA MARKET SNAPSHOT
9.6.2 UAE
9.6.3 SAUDI ARABIA
9.6.4 SOUTH AFRICA
9.6.5 REST OF MIDDLE EAST AND AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE SCENARIO
10.3 COMPANY MARKET RANKING ANALYSIS
10.4 COMPANY REGIONAL FOOTPRINT
10.5 COMPANY INDUSTRY FOOTPRINT
10.6 ACE MATRIX
10.6.1 ACTIVE
10.6.2 CUTTING EDGE
10.6.3 EMERGING
10.6.4 INNOVATORS
11 COMPANY PROFILES
11.1 BIO-TECHNE CORPORATION
11.1.1 COMPANY OVERVIEW
11.1.2 COMPANY INSIGHTS
11.1.3 SEGMENT INSIGHTS
11.1.4 PRODUCT BENCHMARKING
11.1.5 WINNING IMPERATIVES
11.1.6 CURRENT FOCUS & STRATEGIES
11.1.7 THREAT FROM COMPETITION
11.1.8 SWOT ANALYSIS
11.2 TORONTO RESEARCH CHEMICALS
11.2.1 COMPANY OVERVIEW
11.2.2 COMPANY INSIGHTS
11.2.3 PRODUCT BENCHMARKING
11.2.4 WINNING IMPERATIVES
11.2.5 CURRENT FOCUS & STRATEGIES
11.2.6 THREAT FROM COMPETITION
11.2.7 SWOT ANALYSIS
11.3 SANTA CRUZ BIOTECHNOLOGY, INC.
11.3.1 COMPANY OVERVIEW
11.3.2 COMPANY INSIGHTS
11.3.3 PRODUCT BENCHMARKING
11.3.4 WINNING IMPERATIVES
11.3.5 CURRENT FOCUS & STRATEGIES
11.3.6 THREAT FROM COMPETITION
11.3.7 SWOT ANALYSIS
11.4 NANJING PHARMACEUTICAL FACTORY CO., LTD.
11.4.1 COMPANY OVERVIEW
11.4.2 COMPANY INSIGHTS
11.4.3 PRODUCT BENCHMARKING
11.4.4 WINNING IMPERATIVES
11.4.5 CURRENT FOCUS & STRATEGIES
11.4.6 THREAT FROM COMPETITION
11.4.7 SWOT ANALYSIS
11.5 REGIS TECHNOLOGIES
11.5.1 COMPANY OVERVIEW
11.5.2 COMPANY INSIGHTS
11.5.3 PRODUCT BENCHMARKING
11.5.4 KEY DEVELOPMENTS
11.5.5 WINNING IMPERATIVES
11.5.6 CURRENT FOCUS & STRATEGIES
11.5.7 THREAT FROM COMPETITION
11.5.8 SWOT ANALYSIS
11.6 TIANYUAN PHARMACHEMICAL INSTITUTE
11.6.1 COMPANY OVERVIEW
11.6.2 COMPANY INSIGHTS
11.6.3 PRODUCT BENCHMARKING
11.7 AK SCIENTIFIC
11.7.1 COMPANY OVERVIEW
11.7.2 COMPANY INSIGHTS
11.7.3 PRODUCT BENCHMARKING
11.8 MEDCHEMEXPRESS
11.8.1 COMPANY OVERVIEW
11.8.2 COMPANY INSIGHTS
11.8.3 PRODUCT BENCHMARKING
11.9 CHEMSCENCE
11.9.1 COMPANY OVERVIEW
11.9.2 COMPANY INSIGHTS
11.9.3 PRODUCT BENCHMARKING
11.10 ADVACARE PHARMA
11.10.1 COMPANY OVERVIEW
11.10.2 COMPANY INSIGHTS
11.10.3 PRODUCT BENCHMARKING
LIST OF TABLES
TABLE 1 ALTERNATIVES DRUGS USED FOR PROGLUMIDE
TABLE 2 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES
TABLE 3 GLOBAL PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 4 GLOBAL PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 5 GLOBAL PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 6 GLOBAL PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 7 GLOBAL PROGLUMIDE MARKET, BY GEOGRAPHY, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA PROGLUMIDE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 13 U.S. PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 14 U.S. PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 15 U.S. PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 16 U.S. PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 17 CANADA PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 18 CANADA PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 19 CANADA PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 20 CANADA PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 21 MEXICO PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 22 MEXICO PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 23 MEXICO PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 24 MEXICO PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 25 EUROPE PROGLUMIDE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 26 EUROPE PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 27 EUROPE PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 28 EUROPE PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 29 EUROPE PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 30 GERMANY PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 31 GERMANY PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 32 GERMANY PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 33 GERMANY PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 34 U.K. PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 35 U.K. PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 36 U.K. PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 37 U.K. PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 38 FRANCE PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 39 FRANCE PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 40 FRANCE PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 41 FRANCE PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 42 ITALY PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 43 ITALY PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 44 ITALY PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 45 ITALY PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 46 SPAIN PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 47 SPAIN PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 48 SPAIN PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 49 SPAIN PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 50 REST OF EUROPE PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 51 REST OF EUROPE PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 52 REST OF EUROPE PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 53 REST OF EUROPE PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 54 ASIA PACIFIC PROGLUMIDE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 55 ASIA PACIFIC PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 56 ASIA PACIFIC PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 57 ASIA PACIFIC PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 58 ASIA PACIFIC PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 59 CHINA PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 60 CHINA PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 61 CHINA PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 62 CHINA PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 63 JAPAN PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 64 JAPAN PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 65 JAPAN PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 66 JAPAN PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 67 INDIA PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 68 INDIA PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 69 INDIA PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 70 INDIA PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 71 REST OF APAC PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 72 REST OF APAC PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 REST OF APAC PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 74 REST OF APAC PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 75 LATIN AMERICA PROGLUMIDE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 76 LATIN AMERICA PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 LATIN AMERICA PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 78 LATIN AMERICA PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 79 LATIN AMERICA PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 80 BRAZIL PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 81 BRAZIL PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 82 BRAZIL PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 83 BRAZIL PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 84 ARGENTINA PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 85 ARGENTINA PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 86 ARGENTINA PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 87 ARGENTINA PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 88 REST OF LATAM PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 89 REST OF LATAM PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 90 REST OF LATAM PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 91 REST OF LATAM PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 92 MIDDLE EAST AND AFRICA PROGLUMIDE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 93 MIDDLE EAST AND AFRICA PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 94 MIDDLE EAST AND AFRICA PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 95 MIDDLE EAST AND AFRICA PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 96 MIDDLE EAST AND AFRICA PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 97 UAE PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 98 UAE PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 99 UAE PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 100 UAE PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 101 SAUDI ARABIA PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 SAUDI ARABIA PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 103 SAUDI ARABIA PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 104 SAUDI ARABIA PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 105 SOUTH AFRICA PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 SOUTH AFRICA PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 107 SOUTH AFRICA PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 108 SOUTH AFRICA PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 109 REST OF MEA PROGLUMIDE MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 110 REST OF MEA PROGLUMIDE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 111 REST OF MEA PROGLUMIDE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 112 REST OF MEA PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 113 COMPANY REGIONAL FOOTPRINT
TABLE 114 COMPANY INDUSTRY FOOTPRINT
TABLE 115 BIO-TECHNE CORPORATION: PRODUCT BENCHMARKING
TABLE 116 BIO-TECHNE CORPORATION: WINNING IMPERATIVES
TABLE 117 TORONTO RESEARCH CHEMICALS: PRODUCT BENCHMARKING
TABLE 118 TORONTO RESEARCH CHEMICALS: WINNING IMPERATIVES
TABLE 119 SANTA CRUZ BIOTECHNOLOGY, INC.: PRODUCT BENCHMARKING
TABLE 120 SANTA CRUZ BIOTECHNOLOGY, INC.: WINNING IMPERATIVES
TABLE 121 NANJING PHARMACEUTICAL FACTORY CO., LTD.: PRODUCT BENCHMARKING
TABLE 122 NANJING PHARMACEUTICAL FACTORY CO., LTD.: WINNING IMPERATIVES
TABLE 123 REGIS TECHNOLOGIES: PRODUCT BENCHMARKING
TABLE 124 REGIS TECHNOLOGIES: KEY DEVELOPMENTS
TABLE 125 REGIS TECHNOLOGIES: WINNING IMPERATIVES
TABLE 126 TIANYUAN PHARMACHEMICAL INSTITUTE: PRODUCT BENCHMARKING
TABLE 127 AK SCIENTIFIC: PRODUCT BENCHMARKING
TABLE 128 MEDCHEMEXPRESS: PRODUCT BENCHMARKING
TABLE 129 CHEMSCENCE: PRODUCT BENCHMARKING
TABLE 130 ADVACARE PHARMA: PRODUCT BENCHMARKING
LIST OF FIGURES
FIGURE 1 GLOBAL PROGLUMIDE MARKET SEGMENTATION
FIGURE 2 RESEARCH TIMELINES
FIGURE 3 DATA TRIANGULATION
FIGURE 4 MARKET RESEARCH FLOW
FIGURE 5 EXECUTIVE SUMMARY
FIGURE 6 GLOBAL PROGLUMIDE MARKET ESTIMATES AND FORECAST (USD MILLION), 2021-2030
FIGURE 7 GLOBAL PROGLUMIDE MARKET VALUE (USD MILLION) AND FORECAST, 2021-2030
FIGURE 8 GLOBAL PROGLUMIDE ECOLOGY MAPPING (% SHARE IN 2022)
FIGURE 9 COMPETITIVE ANALYSIS: FUNNEL DIAGRAM
FIGURE 10 GLOBAL PROGLUMIDE MARKET ABSOLUTE MARKET OPPORTUNITY
FIGURE 11 GLOBAL PROGLUMIDE MARKET ATTRACTIVENESS ANALYSIS, BY REGION
FIGURE 12 GLOBAL PROGLUMIDE MARKET ATTRACTIVENESS ANALYSIS, BY TYPE
FIGURE 13 GLOBAL PROGLUMIDE MARKET ATTRACTIVENESS ANALYSIS, BY APPLICATION
FIGURE 14 GLOBAL PROGLUMIDE MARKET ATTRACTIVENESS ANALYSIS, BY END-USER
FIGURE 15 GLOBAL PROGLUMIDE MARKET ATTRACTIVENESS ANALYSIS, BY DISTRIBUTION CHANNEL
FIGURE 16 GLOBAL PROGLUMIDE MARKET GEOGRAPHICAL ANALYSIS, 2024-2030
FIGURE 17 GLOBAL PROGLUMIDE MARKET, BY TYPE (USD MILLION)
FIGURE 18 GLOBAL PROGLUMIDE MARKET, BY APPLICATION (USD MILLION)
FIGURE 19 GLOBAL PROGLUMIDE MARKET, BY END-USER (USD MILLION)
FIGURE 20 GLOBAL PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL (USD MILLION)
FIGURE 21 FUTURE MARKET OPPORTUNITIES
FIGURE 22 GLOBAL PROGLUMIDE MARKET OUTLOOK
FIGURE 23 MARKET DRIVERS_IMPACT ANALYSIS
FIGURE 24 NUMBER OF PEPTIC ULCER DISEASE (PUD) DEATH IN 2020
FIGURE 25 PERCENTAGE OF ELDERLY POPULATION GROWTH BY COUNTRY
FIGURE 26 RESTRAINTS_IMPACT ANALYSIS
FIGURE 27 KEY TRENDS
FIGURE 28 PORTER’S FIVE FORCES ANALYSIS
FIGURE 29 VALUE CHAIN ANALYSIS
FIGURE 30 PROGLUMIDE TABLET PRICES BY REGION (USD/MONTH)
FIGURE 31 PRODUCT LIFELINE: GLOBAL PROGLUMIDE MARKET
FIGURE 32 GLOBAL PROGLUMIDE MARKET, BY TYPE
FIGURE 33 GLOBAL PROGLUMIDE MARKET BASIS POINT SHARE (BPS) ANALYSIS, BY TYPE
FIGURE 34 GLOBAL PROGLUMIDE MARKET, BY APPLICATION
FIGURE 35 GLOBAL PROGLUMIDE MARKET BASIS POINT SHARE (BPS) ANALYSIS, BY APPLICATION
FIGURE 36 GLOBAL PROGLUMIDE MARKET, BY END USER
FIGURE 37 GLOBAL PROGLUMIDE MARKET BASIS POINT SHARE (BPS) ANALYSIS, BY END USER
FIGURE 38 GLOBAL PROGLUMIDE MARKET, BY DISTRIBUTION CHANNEL
FIGURE 39 GLOBAL PROGLUMIDE MARKET BASIS POINT SHARE (BPS) ANALYSIS, BY DISTRIBUTION CHANNEL
FIGURE 40 GLOBAL PROGLUMIDE MARKET, BY GEOGRAPHY, 2021-2030 (USD MILLION)
FIGURE 41 U.S. MARKET SNAPSHOT
FIGURE 42 CANADA MARKET SNAPSHOT
FIGURE 43 MEXICO MARKET SNAPSHOT
FIGURE 44 GERMANY MARKET SNAPSHOT
FIGURE 45 U.K. MARKET SNAPSHOT
FIGURE 46 FRANCE MARKET SNAPSHOT
FIGURE 47 ITALY MARKET SNAPSHOT
FIGURE 48 SPAIN MARKET SNAPSHOT
FIGURE 49 REST OF EUROPE MARKET SNAPSHOT
FIGURE 50 CHINA MARKET SNAPSHOT
FIGURE 51 JAPAN MARKET SNAPSHOT
FIGURE 52 INDIA MARKET SNAPSHOT
FIGURE 53 REST OF ASIA PACIFIC MARKET SNAPSHOT
FIGURE 54 BRAZIL MARKET SNAPSHOT
FIGURE 55 ARGENTINA MARKET SNAPSHOT
FIGURE 56 REST OF LATIN AMERICA MARKET SNAPSHOT
FIGURE 57 UAE MARKET SNAPSHOT
FIGURE 58 SAUDI ARABIA MARKET SNAPSHOT
FIGURE 59 SOUTH AFRICA MARKET SNAPSHOT
FIGURE 60 REST OF MIDDLE EAST AND AFRICA MARKET SNAPSHOT
FIGURE 61 KEY STRATEGIC DEVELOPMENTS
FIGURE 62 COMPANY MARKET RANKING ANALYSIS
FIGURE 63 ACE MATRIC
FIGURE 64 BIO-TECHNE CORPORATION: COMPANY INSIGHT
FIGURE 65 BIO-TECHNE CORPORATION: SEGMENT INSIGHT
FIGURE 66 BIO-TECHNE CORPORATION: SWOT ANALYSIS
FIGURE 67 TORONTO RESEARCH CHEMICALS: COMPANY INSIGHT
FIGURE 68 TORONTO RESEARCH CHEMICALS: SWOT ANALYSIS
FIGURE 69 SANTA CRUZ BIOTECHNOLOGY, INC.: COMPANY INSIGHT
FIGURE 70 SANTA CRUZ BIOTECHNOLOGY, INC.: SWOT ANALYSIS
FIGURE 71 NANJING PHARMACEUTICAL FACTORY CO., LTD.: COMPANY INSIGHT
FIGURE 72 NANJING PHARMACEUTICAL FACTORY CO., LTD.: SWOT ANALYSIS
FIGURE 73 REGIS TECHNOLOGIES: COMPANY INSIGHT
FIGURE 74 REGIS TECHNOLOGIES: SWOT ANALYSIS
FIGURE 75 TIANYUAN PHARMACHEMICAL INSTITUTE: COMPANY INSIGHT
FIGURE 76 AK SCIENTIFIC: COMPANY INSIGHT
FIGURE 77 MEDCHEMEXPRESS: COMPANY INSIGHT
FIGURE 78 CHEMSCENCE: COMPANY INSIGHT
FIGURE 79 ADVACARE PHARMA: COMPANY INSIGHT
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
